Availability of Evorel products (Theramex) – Updated

Availability of Evorel products (Theramex) – Updated

September 4, 2020

Following the recent supply problems for the Evorel range of products, Theramex have provided this further update.

‘Since its acquisition by Theramex in October 2019, we have worked tirelessly to relaunch and resupply the Evorel® portfolio to the UK market. We have worked with multiple manufacturing partners to increase production capacity and ensure that Evorel® is readily available to every patient who needs it.

We are now delighted to announce that the full Evorel® range is back in stock. We would like to thank both patients and healthcare professionals for their patience as we stabilised the supply chain. In addition, we thank GPs across the UK for prescribing responsibly as we replenished the market.’


Further information

In order to ensure the widest possible reach of the available stock, Alliance Healthcare have applied monthly quotas to the volume of stock available to individual pharmacists. If you require additional stock above this quota, in order to fulfil prescriptions, please contact Alliance Healthcare Customer Service by telephone 0330 100 0448 or email customerservice@alliance-healthcare.co.uk.

Theramex will continue to provide regular updates via their website.

The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need  an NHS email address. Once set up and logged in, you will be able to access it online.

New shortages not listed on the SPS website, can be reported using our shortage reporting tool.

Please report your experiences of difficulties obtaining stock due to quota restrictions here

Posted in:

More Latest News >